- Home
- OTLK vs UFG Comparison
OTLK vs UFG Comparison
Compare OTLK & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTLK | UFG |
|---|---|---|
| Founded | 2010 | 2021 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 31.3M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | OTLK | UFG |
|---|---|---|
| Price | $0.44 | $1.05 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 340.0K |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,146,123.00 | N/A |
| Revenue This Year | $1,726.70 | $41.40 |
| Revenue Next Year | $80.34 | $25.00 |
| P/E Ratio | ★ N/A | $211.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $0.60 |
| 52 Week High | $3.39 | $9.91 |
Technical Indicators
Market Signals| Indicator | OTLK | UFG |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 45.95 |
| Support Level | $0.39 | $0.98 |
| Resistance Level | $0.46 | $1.16 |
| Average True Range (ATR) | 0.03 | 0.11 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 68.45 | 18.33 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About UFG Uni-Fuels Holdings Limited
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.